Galderma Group AG (XSWX:GALD) Receivables Turnover : 2.66 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Galderma Group AG's Revenue for the six months ended in Dec. 2024 was CHF1,983 Mil. Galderma Group AG's average Accounts Receivable for the six months ended in Dec. 2024 was CHF745 Mil. Hence, Galderma Group AG's Receivables Turnover for the six months ended in Dec. 2024 was 2.66.

Galderma Group AG Receivables Turnover Historical Data

The historical data trend for Galderma Group AG's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Receivables Turnover Chart

Galderma Group AG Annual Data

Trend

Dec23

Dec24

Receivables Turnover

6.52

6.50

Galderma Group AG Semi-Annual Data
	Jun23	Dec23	Jun24	Dec24
Receivables Turnover	-	3.33	2.90	2.66

Competitive Comparison of Galderma Group AG's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Galderma Group AG Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Galderma Group AG's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

	Receivables Turnover (A: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2024 )	/ (	(Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )
=	3958.704	/ (	(545.689	+	672.266)	/	2 )
=	3958.704	/	608.9775
=	6.50

Galderma Group AG's Receivables Turnover for the quarter that ended in Dec. 2024 is calculated as

	Receivables Turnover (Q: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2024 )	/ (	(Accounts Receivable (Q: Jun. 2024 )	+	Accounts Receivable (Q: Dec. 2024 ))	/	count )
=	1982.918	/ (	(818.721	+	672.266)	/	2 )
=	1982.918	/	745.4935
=	2.66

Galderma Group AG (XSWX:GALD) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Galderma Group AG Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

GALDY:USA GDERF:USA GALDz:UK PY30:Germany

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines